Skip to content

Charles River Laboratories CRL RMS — Intangible asset impairment

Other segment segments

Manufacturing
$108.97M

Similar metrics at other companies

StoneX Group Inc. logo
SNEXImpairment of intangible assets
$4.6M-71.6%
Leonardo DRS, Inc. logo
DRSIMS — Accumulated impairment
$606M
Marsh logo
MRSHRisk and Insurance Services — Intangible Amortization
$119M-0.8%
EnerSys logo
ENSEMEA — Impairment of intangible assets
$0
ImmunityBio, Inc. logo
IBRXSegment Reporting — Impairment of intangible assets
$0
Glaukos logo
GKOSCost Of Impairment Of Intangible Assets
$28.22M

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfIntangibleAssetsFinitelived.

The official record: Charles River Laboratories’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's rms — intangible asset impairment.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's RMS — intangible asset impairment?
Charles River Laboratories (CRL) reported RMS — intangible asset impairment of $52.75M in Q4 2025.
What does RMS — intangible asset impairment mean?
This metric reflects the non-cash charge recognized when the carrying value of intangible assets within the Research Models and Services segment exceeds their fair value. It indicates a reduction in the expected future economic benefits of acquired assets like patents, customer relationships, or technology.